Home›India›AYUSH›Pharmacopoeia Commission for Indian Medicine & Homoeopathy (...
Date: 2026-05-18Category: Press ReleaseState: Union GovernmentCountry: India
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) Organizes 5-Day Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders
**Executive Summary**
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is conducting a five-day Capacity Building Training Program from May 18 to 22, 2026. The program aims to strengthen quality standards, technical skills, and regulatory knowledge for 28 selected stakeholders in the Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) sectors. By combining expert-led lectures with hands-on laboratory training and industrial visits, the initiative seeks to reinforce India’s leadership in the global standardization of traditional medicine.
**Key Points / Main Content**
**Program Objectives and Scope**
* Focuses on enhancing the professional capabilities of stakeholders associated with regulatory, academic, quality control, and manufacturing sectors.
* Aims to promote global acceptance of ASU&H systems by adopting modern instruments and advanced scientific techniques for drug development.
* Addresses the increasing international demand for recognized pharmacopoeias and formularies.
**Technical Curriculum**
* Covers essential regulatory frameworks, including NABL Accreditation, Quality Management Systems (QMS), and Good Manufacturing Practices (GMP).
* Provides specialized training in the evaluation of ASU&H drugs through pharmacognostic, physico-chemical, phytochemical, microbiological, and pharmacological methods.
* Includes detailed modules on the standardization of herbal drugs, shelf-life studies, and pharmacopoeial aspects.
**Practical and Field Training**
* Participants undergo hands-on laboratory training directly at PCIM&H facilities.
* Includes field visits to major manufacturing units, such as Dr. Willmar Schwabe India Pvt. Ltd. (Noida) and Hamdard Laboratories India (Ghaziabad), to observe modern quality assurance systems.
**Participant Profile**
* The program hosts 28 participants including State Drug Controllers, Drug Inspectors, and Research Officers.
* Attendees represent diverse institutions such as the Central Drugs Laboratory (Kolkata), National Institute of Siddha (Chennai), and the Regional Ayurveda Research Institute (CCRAS).
**Impact Analysis**
**Drug Regulators and Enforcement Authorities**
**Impact**
They gain updated knowledge on regulatory standards and pharmacopoeial requirements necessary for effective oversight of the ASU&H sector.
**Action Required**
Apply strengthened regulatory knowledge to monitor compliance and enforce quality standards within their respective jurisdictions.
**Quality Control Personnel and Researchers**
**Impact**
Technical skills are enhanced through exposure to advanced scientific evaluation techniques and modern laboratory practices.
**Action Required**
Implement standardized testing protocols and advanced phytochemical or microbiological evaluations in their research and testing facilities.
**ASU&H Manufacturing Units**
**Impact**
Participants from manufacturing sectors gain practical exposure to modern technologies and industry-leading quality assurance systems.
**Action Required**
Align manufacturing processes with Good Manufacturing Practices (GMP) and adopt updated shelf-life study methodologies to ensure product quality for global markets.
Key Entities Referenced
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H): The primary regulatory body under the Ministry of Ayush responsible for developing quality standards and pharmacopoeias for traditional medicine systems.
Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders: A five-day technical initiative designed to strengthen the regulatory knowledge, technical skills, and quality control capabilities of personnel in the ASU&H sector.
Ministry of Ayush: The central government ministry overseeing the policy, development, and regulation of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy in India.
National Medicinal Plants Board (NMPB): An agency under the Ministry of Ayush involved in coordinating matters related to medicinal plants used in the production of ASU&H medicines.
AYUSH
Pharmacopoeia Commission for Indian Medicine
& Homoeopathy (PCIM&H) Organizes 5-Day
Capacity Building Training Program for ASU&H
Drug Regulators and Stakeholders
Training Program focuses on strengthening quality standards,
regulatory knowledge and technical capabilities in ASU&H
sector
Posted On: 18 MAY 2026 8:59PM by PIB Delhi
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is
organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme
is being conducted for drug regulators, enforcement authorities, quality control personnel, technical
experts, faculty members, government analysts, researchers and scientists working in the field of
Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines.
The programme aims to strengthen the knowledge, technical skills and professional capabilities of
stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of
ASU&H drug development.
The inaugural session of the programme was graced by Ms. Jaspal Kaur Pradyot, Chief Controller of
Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated
PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs
through the adoption of modern instruments and advanced scientific techniques. She also highlighted the
rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity.
Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of
Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of
the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and
acceptance of ASU&H systems of medicine.
Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an
overview of the organization and highlighted its key activities in the standardization and quality control of
ASU&H medicines.
During the five-day programme, participants will receive expert-led lectures on various important aspects
including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices
(GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological
evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and
pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs.Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to
leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and
Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern
technologies, manufacturing practices and quality assurance systems adopted in the industry.
The programme has attracted 28 participants from across the country representing a diverse range of
institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty
Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and
Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute,
Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and
Jhansi; and ASU&H drug manufacturing units.
This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting
professional excellence and strengthening quality standards within the ASU&H sector. By equipping
stakeholders with updated technical knowledge and practical expertise, the programme seeks to further
reinforce India’s leadership in the global regulation, standardization and development of traditional
systems of medicine.***
SR/SV/SG
(Release ID: 2262543) Visitor Counter : 133
Read this release in: ही , Tamil